Benchmark Upgrades Axcelis Technologies (NASDAQ:ACLS) to Buy

Key Points

• Benchmark has upgraded Axcelis Technologies from a "hold" to a "buy" rating, setting a price objective of $105.00, which reflects a potential upside of 10.81% from its current price.
• The company recently reported earnings of $1.13 per share, which surpassed analysts' expectations of $0.73, alongside a quarterly revenue of $194.54 million.
• Axcelis Technologies stock has shown volatility, with a 12-month range of $40.40 to $107.23, and institutional investors hold 89.98% of its shares.

Axcelis Technologies (NASDAQ:ACLS - Get Free Report) was upgraded by investment analysts at Benchmark from a "hold" rating to a "buy" rating in a report released on Thursday,Finviz reports. The firm currently has a $105.00 price objective on the semiconductor company's stock. Benchmark's price objective indicates a potential upside of 10.81% from the company's current price.

Several other research firms have also recently commented on ACLS. B. Riley upped their price target on Axcelis Technologies from $58.00 to $75.00 and gave the stock a "neutral" rating in a research note on Wednesday, June 18th. DA Davidson lifted their price target on Axcelis Technologies from $75.00 to $90.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Three research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $93.75.

Axcelis Technologies Trading Down 2.9%

Shares of Axcelis Technologies stock opened at $94.76 on Thursday. Axcelis Technologies has a 12-month low of $40.40 and a 12-month high of $107.23. The stock has a market cap of $2.98 billion, a price-to-earnings ratio of 19.38 and a beta of 1.75. The company has a current ratio of 6.01, a quick ratio of 4.26 and a debt-to-equity ratio of 0.04. The company has a fifty day simple moving average of $83.19 and a 200-day simple moving average of $67.64.

Axcelis Technologies (NASDAQ:ACLS - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The semiconductor company reported $1.13 earnings per share for the quarter, beating analysts' consensus estimates of $0.73 by $0.40. The company had revenue of $194.54 million during the quarter, compared to analysts' expectations of $185.15 million. Axcelis Technologies had a return on equity of 16.26% and a net margin of 17.69%.The firm's revenue for the quarter was down 24.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.55 earnings per share. Axcelis Technologies has set its Q3 2025 guidance at 1.000-1.000 EPS. On average, equities analysts forecast that Axcelis Technologies will post 2.55 EPS for the current fiscal year.

Institutional Investors Weigh In On Axcelis Technologies

A number of large investors have recently modified their holdings of the stock. Vanguard Group Inc. boosted its stake in shares of Axcelis Technologies by 1.0% during the 1st quarter. Vanguard Group Inc. now owns 4,439,902 shares of the semiconductor company's stock valued at $220,530,000 after buying an additional 43,768 shares during the last quarter. American Century Companies Inc. boosted its stake in Axcelis Technologies by 45.5% during the 2nd quarter. American Century Companies Inc. now owns 1,659,463 shares of the semiconductor company's stock valued at $115,648,000 after purchasing an additional 518,968 shares in the last quarter. Reinhart Partners LLC. lifted its holdings in Axcelis Technologies by 5.4% in the 2nd quarter. Reinhart Partners LLC. now owns 1,518,544 shares of the semiconductor company's stock valued at $105,828,000 after acquiring an additional 77,522 shares during the last quarter. Primecap Management Co. CA boosted its position in shares of Axcelis Technologies by 2.1% during the 2nd quarter. Primecap Management Co. CA now owns 852,296 shares of the semiconductor company's stock valued at $59,397,000 after purchasing an additional 17,230 shares in the last quarter. Finally, Boston Trust Walden Corp raised its holdings in shares of Axcelis Technologies by 2.4% in the 2nd quarter. Boston Trust Walden Corp now owns 845,911 shares of the semiconductor company's stock worth $58,952,000 after purchasing an additional 19,579 shares in the last quarter. Institutional investors and hedge funds own 89.98% of the company's stock.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.